Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,169 | 1,244 | 1,057 | 258 | 763 |
| Gross Profit | 1,169 | 1,244 | 1,057 | 258 | 763 |
| Operating Expenses | 3,477 | 3,793 | 3,994 | 3,458 | 4,897 |
| Operating Income | -2,308 | -2,549 | -2,938 | -3,200 | -4,134 |
| Other Income | 115 | 156 | 201 | 218 | 35 |
| Pre-tax Income | -2,193 | -2,393 | -2,737 | -2,982 | -4,099 |
| Net Income Continuous | -2,193 | -2,393 | -2,740 | -2,982 | -4,099 |
| Net Income Discontinuous | N/A | N/A | -63 | N/A | 6,615 |
| Net Income | $-2,193 | $-2,393 | $-2,803 | $-2,982 | $2,516 |
| EPS Basic Total Ops | -0.25 | -0.27 | -0.32 | -0.34 | 0.29 |
| EPS Basic Continuous Ops | -0.25 | -0.27 | -0.30 | -0.34 | -0.47 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.00 | N/A | 0.75 |
| EPS Diluted Total Ops | -0.25 | -0.27 | -0.32 | -0.34 | 0.29 |
| EPS Diluted Continuous Ops | -0.25 | -0.27 | -0.30 | -0.34 | -0.47 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.00 | N/A | 0.75 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.27 | N/A | N/A | N/A |
| EBITDA(a) | $-2,308 | $-2,549 | $-2,938 | $-3,200 | $-4,134 |